{"gene":"COMT","run_date":"2026-04-28T17:28:53","timeline":{"discoveries":[{"year":1996,"finding":"A G→A transition at codon 158 of the COMT gene (Val158Met) causes a 3- to 4-fold variation in COMT enzyme activity; the Met158 allele encodes a thermolabile, low-activity enzyme, while Val158 encodes a high-activity, thermostable form.","method":"PCR-RFLP genotyping combined with enzyme activity assays in human red blood cells and lymphocytes","journal":"Pharmacogenetics","confidence":"High","confidence_rationale":"Tier 1 — direct biochemical assay establishing catalytic consequences of variant; replicated extensively across labs","pmids":["8807664"],"is_preprint":false},{"year":2001,"finding":"Recombinant wild-type COMT (108Val) and variant COMT (108Met) differ in catechol estrogen methylation: the Met variant is thermolabile and shows 2-3-fold lower catalytic activity toward 2-OHE2, 4-OHE2, 2-OHE1, and 4-OHE1. Methylation of 4-OH catechol estrogens occurs only at the 4-OH group, while 2-OH catechol estrogens are methylated at both 2-OH and 3-OH positions.","method":"Recombinant His-tagged COMT isoforms purified by nickel chromatography; GC/MS quantitation of methoxy products; comparison with MCF-7 and ZR-75 breast cancer cell lines with matched genotypes","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro enzyme assay with purified recombinant proteins and orthogonal cell-based validation","pmids":["11559542"],"is_preprint":false},{"year":2001,"finding":"A kinetic model using published Km/Vmax values of recombinant MB-COMT and S-COMT indicates that in human brain, where MB-COMT constitutes ~70% of total COMT protein, MB-COMT predominates in the O-methylation of dopamine and noradrenaline at low (physiological) concentrations; in rat brain (MB-COMT ~30%), S-COMT predominates for L-DOPA and 3,4-dihydroxybenzoic acid. The meta/para product ratio is higher for MB-COMT than S-COMT.","method":"Enzyme kinetic modeling using published in vitro Km/Vmax values for recombinant isoforms combined with published tissue composition data","journal":"Medical hypotheses","confidence":"Medium","confidence_rationale":"Tier 1 kinetic data but derived from computational modeling, not direct experiment in intact tissue","pmids":["11735324"],"is_preprint":false},{"year":2001,"finding":"COMT Val158Met genotype predicts prefrontal cognitive performance (Wisconsin Card Sorting Test perseverative errors) in an allele-dosage fashion, with Met allele load associated with better executive function; COMT Val158Met also predicts efficiency of prefrontal cortical physiological response during working memory measured by fMRI; Val allele transmission was increased in schizophrenia trios.","method":"Neuropsychological testing + fMRI during working memory task in patients, siblings and controls stratified by COMT genotype; family-based transmission disequilibrium test","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — convergent evidence from behavioral, neuroimaging, and genetic transmission analyses across large cohorts; highly cited foundational study","pmids":["11381111"],"is_preprint":false},{"year":2003,"finding":"COMT Val158Met genotype modulates mu-opioid neurotransmitter responses to sustained pain: Met158 homozygotes show diminished regional mu-opioid system activation (measured by PET with [11C]carfentanil), higher sensory and affective pain ratings, and more negative affect; Val158 homozygotes show opposite effects.","method":"PET neuroimaging with mu-opioid receptor radioligand [11C]carfentanil during sustained experimental pain, stratified by COMT Val158Met genotype","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 — direct in vivo neurochemical measurement (receptor binding/occupancy) linking COMT genotype to endogenous opioid system function","pmids":["12595695"],"is_preprint":false},{"year":2004,"finding":"Three common COMT haplotypes (LPS, APS, HPS), defined by combinations of synonymous and one nonsynonymous SNP, determine COMT enzymatic activity inversely correlating with pain sensitivity. The LPS haplotype produces the highest enzymatic activity and is associated with reduced risk of temporomandibular disorder. Pharmacological inhibition of COMT in rats produces a profound increase in pain sensitivity.","method":"Haplotype analysis in human cohorts; COMT enzyme activity assays; rat model with COMT inhibitor administration and behavioral pain testing","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1-2 — combines human genetic haplotype/enzyme activity data with direct pharmacological intervention in animal model, multiple orthogonal methods","pmids":["15537663"],"is_preprint":false},{"year":2005,"finding":"The Ala72Ser substitution in COMT (rs6267; codon 22/72 in soluble/membrane-bound form respectively) reduces COMT enzyme activity and is associated with increased schizophrenia risk in Koreans, while the Val158Met polymorphism was not associated in this population.","method":"Enzyme activity assays in lymphocyte samples stratified by Ala72Ser genotype; case-control association study (320 patients, 379 controls)","journal":"Human genetics","confidence":"Medium","confidence_rationale":"Tier 2 — direct enzyme activity measurement linked to coding variant; single population study","pmids":["15645182"],"is_preprint":false},{"year":2006,"finding":"Three common COMT haplotypes that differ at two synonymous positions (in addition to Val158Met) produce the largest differences in enzymatic activity primarily due to differences in the amount of translated protein. These synonymous variants alter mRNA local stem-loop secondary structure; more stable stem-loops correlate with lower protein levels and lower enzymatic activity. Site-directed mutagenesis eliminating the stable stem-loop structure restores translated protein levels.","method":"Luciferase reporter assays with COMT haplotype constructs; quantitative Western blotting; computational RNA secondary structure prediction; site-directed mutagenesis","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 — reconstitution with reporters, mutagenesis rescue, and structural prediction converge on a single mechanism","pmids":["17185601"],"is_preprint":false},{"year":2007,"finding":"Multiple COMT variant mRNAs are expressed in human frontal cortex, resulting from insertions and deletions within the known brain transcript; several alter the predicted coding sequence. These variants are differentially distributed across brain regions.","method":"RT-PCR with intron-spanning primers across all exon-to-exon combinations; sequencing confirmation; regional RT-PCR characterization","journal":"American journal of medical genetics. Part B, Neuropsychiatric genetics","confidence":"Medium","confidence_rationale":"Tier 2 — direct molecular characterization of transcript variants; single lab, functional consequences not fully defined","pmids":["17477346"],"is_preprint":false},{"year":2008,"finding":"High-activity COMT Val158 carriers have significantly higher plasma total homocysteine levels than Met158 homozygotes, an effect limited to individuals homozygous for the MTHFR T677 allele. This demonstrates that COMT activity influences homocysteine metabolism via generation of S-adenosylhomocysteine (SAH), a homocysteine precursor, and shows interaction with the SAM-regenerating enzyme MTHFR.","method":"Plasma total homocysteine measurement in 780 elderly individuals stratified by COMT Val158Met and MTHFR C677T genotypes; interaction analysis","journal":"American journal of medical genetics. Part B, Neuropsychiatric genetics","confidence":"Medium","confidence_rationale":"Tier 2 — links COMT catalytic activity to a defined biochemical pathway (SAH/homocysteine) in vivo; single study but mechanistically coherent","pmids":["18189241"],"is_preprint":false},{"year":2011,"finding":"Estrogen regulates COMT activity in a sex- and tissue-dependent manner in rats: estradiol down-regulates COMT protein in prefrontal cortex and kidneys but doubles COMT protein in prostate; tamoxifen (estrogen antagonist) increases COMT protein in multiple central and peripheral tissues. COMT activity does not always parallel COMT protein levels.","method":"In vivo estradiol and tamoxifen treatment of male/female/ovariectomized Wistar rats; COMT enzyme activity assays and COMT protein quantification in multiple tissues","journal":"Journal of physiology and pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 — direct pharmacological manipulation in vivo with both activity and protein measurements; single study","pmids":["22100850"],"is_preprint":false},{"year":2011,"finding":"COMT-deficient (knockout) mice show increased corticosterone response to acute but not chronic restraint stress, and a modified cytokine profile after chronic but not acute stress. Female COMT KO mice display increased anxiety behavior and altered benzodiazepine sensitivity, indicating COMT modulates stress-related hormonal and immune parameters in a stressor-chronicity-dependent manner.","method":"COMT KO mice (heterozygous and homozygous); serum corticosterone and cytokine measurement after acute vs. chronic restraint; light-dark anxiety test with benzodiazepine administration","journal":"Behavioural brain research","confidence":"Medium","confidence_rationale":"Tier 2 — genetic loss-of-function with defined neuroendocrine phenotypic readouts; single lab","pmids":["22192380"],"is_preprint":false},{"year":2012,"finding":"ZNF804a, a C2H2 zinc-finger transcription factor, directly binds chromatin proximal to the COMT promoter region and upregulates COMT transcript levels. Chromatin immunoprecipitation (ChIP) demonstrated both epitope-tagged and endogenous ZNF804a interaction with COMT promoter sequences.","method":"ZNF804a overexpression with quantitative RT-PCR for COMT mRNA; chromatin immunoprecipitation (ChIP) with both tagged and endogenous ZNF804a; immunocytochemistry confirming nuclear localization in rat neural progenitors","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — reciprocal ChIP with endogenous and tagged protein plus functional mRNA quantification; single lab","pmids":["22384243"],"is_preprint":false},{"year":2013,"finding":"COMT hemizygosity in 22q11.2 deletion syndrome results in approximately 50% reduction in COMT mRNA, protein, and enzyme activity. Haplotype analysis reveals that different Val-containing haplotypes differ in their effects on soluble COMT (S-COMT) and membrane-bound COMT (MB-COMT) protein levels and enzyme activity. The 3'UTR SNP rs165599 G variant is associated with low COMT expression. A rare COMT mutation (rs74745580 'T') is associated with absent S-COMT expression and near-absent enzyme activity.","method":"COMT mRNA quantification, protein expression (Western blot), and enzyme activity assays in lymphoblast samples from 22q11.2DS patients and controls; haplotype analysis","journal":"Biological psychiatry","confidence":"High","confidence_rationale":"Tier 1-2 — concurrent mRNA, protein, and enzyme activity measurements in genetically defined patient samples with multiple haplotype contrasts","pmids":["23992923"],"is_preprint":false},{"year":2013,"finding":"Genetic reduction of either COMT or DTNBP1 (dysbindin) alone produces working memory advantages in mice, but combined reduction of both produces working memory deficits — a non-linear epistatic interaction. This same non-linear interaction is observed in human fMRI: COMT Met158 homozygotes (reduced COMT activity) show more efficient prefrontal engagement, but this advantage is reversed on the background of a DTNBP1 haplotype associated with decreased expression.","method":"COMT KO × DTNBP1 KO double-mutant mouse working memory behavioral testing; fMRI during working memory in 176 healthy volunteers stratified by COMT and DTNBP1 genotypes","journal":"Molecular psychiatry","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis demonstrated in both animal model and human neuroimaging with convergent non-linear result","pmids":["24145376"],"is_preprint":false},{"year":2016,"finding":"In the olfactory bulb (OB), COMT is the predominant mechanism for dopamine clearance rather than the dopamine transporter (DAT). The OB contains ~50% more COMT per unit tissue than the dopamine-rich striatum and far less DAT. Optical activation of short axon cells (SACs) expressing ChR2 in TH-containing neurons evokes dopamine release measured by fast-scan cyclic voltammetry; the COMT inhibitor tolcapone increases the DA signal ~2-fold, whereas the DAT inhibitor GBR12909 has no effect.","method":"Fast-scan cyclic voltammetry; optogenetic stimulation (ChR2 in TH-Cre mice); pharmacological COMT inhibition with tolcapone; Western blot quantification of COMT and DAT protein across brain regions","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1-2 — direct functional measurement of dopamine clearance with pharmacological inhibition and optogenetic release, orthogonal to protein quantification","pmids":["27445153"],"is_preprint":false},{"year":2017,"finding":"Transgenic mice overexpressing human COMT have lower basal striatal dopamine levels and, after 6-OHDA lesion and chronic L-DOPA treatment, exhibit exacerbated L-DOPA-induced dyskinesia with potentiated induction of FosB and phospho-acetylated histone 3 (molecular markers of dyskinesia) in the lesioned striatum. L-DOPA produces a greater increase in the dopamine metabolite 3-methoxytyramine in dyskinetic COMT-overexpressing mice, confirming enhanced COMT-mediated dopamine catabolism.","method":"Human COMT transgenic mouse model; 6-OHDA lesion; chronic L-DOPA treatment; dyskinesia scoring; striatal dopamine/metabolite HPLC; FosB and histone immunohistochemistry","journal":"Neurobiology of disease","confidence":"High","confidence_rationale":"Tier 2 — gain-of-function transgenic model with defined neurochemical and molecular phenotype, multiple orthogonal readouts","pmids":["28315782"],"is_preprint":false},{"year":2018,"finding":"In human prefrontal cortex (postmortem), COMT SNPs rs4680 (Val158Met) and rs4818 are associated with varying levels of soluble COMT (S-COMT) protein but not membrane-bound COMT (MB-COMT), indicating that genotype influences S-COMT abundance independently of MB-COMT. SNPs rs737865 and rs165599 showed no association with either isoform.","method":"Western blotting for S-COMT and MB-COMT protein in postmortem prefrontal cortex from 199 subjects with defined COMT genotypes at four SNPs; statistical association analysis stratified by diagnosis","journal":"Journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 2 — direct protein quantification of two isoforms linked to specific SNPs in human tissue; single study","pmids":["30218069"],"is_preprint":false},{"year":2019,"finding":"In iPSC-derived dopaminergic neurons from Parkinson's disease patients with PARK2 mutations, COMT expression is dramatically increased relative to healthy controls, associated with lower DNA methylation at the COMT locus. Isogenic PARK2 knockout lines (by CRISPR-Cas9) show the same COMT upregulation. Cell-type-specific overexpression of COMT in dopaminergic neurons of DAT-Cre mice produces cataleptic behavior and impaired motor coordination.","method":"iPSC differentiation to dopaminergic neurons; CRISPR-Cas9 isogenic PARK2 KO; RNA-seq and bisulfite sequencing for methylation; viral vector cell-type-specific COMT overexpression in DAT-Cre mice with behavioral phenotyping","journal":"Brain","confidence":"High","confidence_rationale":"Tier 1-2 — isogenic CRISPR model plus in vivo cell-type-specific OE with defined motor phenotype; multiple orthogonal approaches","pmids":["31135049"],"is_preprint":false},{"year":2011,"finding":"COMT-deficient pregnant mice develop a preeclampsia-like phenotype that is reversed by exogenous 2-methoxyestradiol (2-ME), an estrogen metabolite generated by COMT. 2-ME inhibits Hypoxia Inducible Factor 1α (HIF-1α), a transcription factor mediating hypoxic responses, linking COMT enzymatic activity to placental angiogenesis via the 2-ME/HIF-1α pathway.","method":"COMT KO pregnant mouse phenotyping; 2-ME supplementation rescue experiment; human genetic study of COMT and MTHFR haplotypes in preeclampsia cohort","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — genetic KO with pharmacological rescue identifies mechanistic pathway; human genetic epistasis data supporting mechanism","pmids":["21304959"],"is_preprint":false}],"current_model":"COMT encodes a magnesium-dependent O-methyltransferase (expressed as soluble S-COMT and membrane-bound MB-COMT isoforms) that inactivates catecholamines (dopamine, norepinephrine, epinephrine), catechol estrogens, and catechol drugs via S-adenosylmethionine-dependent O-methylation; a Val158Met coding polymorphism causes a ~3-4-fold difference in enzyme activity (Val=high, Met=low/thermolabile) that is further modulated by synonymous haplotype variants altering mRNA stem-loop structure and protein translation efficiency, thereby governing prefrontal dopamine levels (with MB-COMT predominating in human brain), mu-opioid system responses to pain, and downstream pathways including homocysteine production (via SAH) and 2-methoxyestradiol/HIF-1α-mediated placental angiogenesis; in the olfactory bulb, COMT rather than the dopamine transporter is the primary mechanism of synaptic dopamine clearance, and cell-type-specific overexpression or loss in dopaminergic neurons produces motor and cognitive phenotypes in rodent models."},"narrative":{"teleology":[{"year":1996,"claim":"Establishing how a single coding variant controls COMT catalytic output: the Val158Met polymorphism was shown to cause a 3–4-fold difference in enzyme activity and thermostability, providing the first mechanistic basis for inter-individual variation in catecholamine metabolism.","evidence":"PCR-RFLP genotyping with enzyme activity assays in human erythrocytes and lymphocytes","pmids":["8807664"],"confidence":"High","gaps":["Crystal-structure basis for thermolability not defined in this study","Effect on MB-COMT isoform not directly measured"]},{"year":2001,"claim":"Defining substrate scope and isoform partitioning: recombinant enzyme assays demonstrated that Val158Met modulates catechol estrogen methylation with regioselectivity, while kinetic modeling showed that MB-COMT predominates in human brain dopamine O-methylation at physiological concentrations.","evidence":"Purified recombinant S-COMT and MB-COMT kinetic assays (GC/MS quantitation); kinetic modeling from published Km/Vmax values; validation in breast cancer cell lines","pmids":["11559542","11735324"],"confidence":"High","gaps":["Kinetic model not validated by direct isoform-selective measurement in intact brain tissue","Relative contribution of each isoform to catechol estrogen metabolism in vivo unknown"]},{"year":2001,"claim":"Linking COMT genotype to prefrontal cognition: Val158Met was shown to predict executive function performance and prefrontal cortical efficiency in an allele-dosage manner, establishing that dopamine catabolism by COMT is rate-limiting for prefrontal cortical function.","evidence":"Neuropsychological testing (WCST) and fMRI during working memory in patients, siblings, and controls stratified by genotype; transmission disequilibrium test in schizophrenia trios","pmids":["11381111"],"confidence":"High","gaps":["Causal directionality (dopamine level vs. downstream signaling) not resolved","Contribution of other prefrontal catecholamine-metabolizing pathways not excluded"]},{"year":2003,"claim":"Extending COMT's functional reach beyond dopamine cognition: PET imaging revealed that Val158Met genotype modulates endogenous mu-opioid system responses to sustained pain, connecting catecholamine metabolism to opioid neurotransmission and pain processing.","evidence":"PET with [11C]carfentanil during experimental sustained pain, stratified by COMT genotype","pmids":["12595695"],"confidence":"High","gaps":["Molecular pathway linking catechol metabolism to mu-opioid receptor activation not identified","Whether the effect is dopamine- or norepinephrine-mediated is unresolved"]},{"year":2006,"claim":"Revealing that synonymous haplotype variants, not Val158Met alone, are the dominant determinant of COMT enzyme output: synonymous SNPs alter mRNA local stem-loop structure, reducing translational efficiency and protein abundance, providing a post-transcriptional regulatory mechanism.","evidence":"Luciferase reporter assays with haplotype constructs; quantitative Western blotting; RNA structure prediction; site-directed mutagenesis rescue","pmids":["17185601"],"confidence":"High","gaps":["In vivo validation of stem-loop-mediated translational control in brain tissue not performed","Whether ribosome profiling data support the model is unknown"]},{"year":2008,"claim":"Connecting COMT catalysis to one-carbon metabolism: high-activity COMT Val158 carriers showed elevated plasma homocysteine (via SAH production), with an epistatic interaction with MTHFR C677T, establishing that COMT activity feeds into methionine cycle intermediates.","evidence":"Plasma homocysteine measurement in 780 elderly subjects stratified by COMT and MTHFR genotypes","pmids":["18189241"],"confidence":"Medium","gaps":["Direct measurement of SAH flux attributable to COMT not performed","Replication in younger cohorts or different populations not reported"]},{"year":2011,"claim":"Identifying a non-catecholamine pathway for COMT in reproduction: COMT-deficient pregnant mice developed preeclampsia-like features reversed by the COMT product 2-methoxyestradiol, linking COMT to placental angiogenesis via 2-ME/HIF-1α inhibition.","evidence":"COMT KO pregnant mouse phenotyping with 2-ME rescue; human COMT/MTHFR haplotype association in preeclampsia cohort","pmids":["21304959"],"confidence":"Medium","gaps":["Human causal evidence limited to genetic association","Quantitative contribution of COMT vs. other methyltransferases to 2-ME production in human placenta not defined"]},{"year":2013,"claim":"Quantifying the functional consequence of COMT hemizygosity: in 22q11.2 deletion syndrome, COMT mRNA, protein, and enzyme activity are halved, and haplotype-specific effects on S-COMT vs. MB-COMT were resolved, including a rare variant ablating S-COMT expression.","evidence":"Concurrent mRNA, Western blot, and enzyme activity assays in 22q11.2DS patient lymphoblasts with full haplotype characterization","pmids":["23992923"],"confidence":"High","gaps":["Consequences for brain dopamine levels in 22q11.2DS patients not directly measured","Functional impact of rare S-COMT-null variant not tested in neuronal cells"]},{"year":2013,"claim":"Demonstrating non-linear epistasis in dopamine signaling: combined reduction of COMT and DTNBP1 reverses the working memory advantage seen with either reduction alone, in both mouse models and human fMRI, establishing that prefrontal dopamine function follows an inverted-U relationship dependent on multiple genetic inputs.","evidence":"COMT KO × DTNBP1 KO double-mutant mice behavioral testing; fMRI in 176 subjects stratified by both genotypes","pmids":["24145376"],"confidence":"High","gaps":["Molecular mechanism of COMT–DTNBP1 interaction at the synaptic level not defined","Whether the epistasis extends to pain or other COMT-dependent phenotypes unknown"]},{"year":2016,"claim":"Establishing COMT as the dominant dopamine clearance mechanism in the olfactory bulb: optogenetic dopamine release combined with pharmacological inhibition showed that tolcapone (COMT inhibitor) but not a DAT inhibitor prolonged dopamine signals, challenging the assumption that DAT is universally the primary clearance route.","evidence":"Fast-scan cyclic voltammetry with optogenetic stimulation in TH-Cre mice; tolcapone vs. GBR12909; COMT/DAT protein quantification across brain regions","pmids":["27445153"],"confidence":"High","gaps":["Whether other brain regions with low DAT similarly depend on COMT clearance is unexplored","Contribution of extracellular vs. intracellular COMT not dissected"]},{"year":2019,"claim":"Linking COMT dysregulation to Parkinson's disease pathology: PARK2-mutant iPSC-derived dopaminergic neurons show COMT upregulation via DNA hypomethylation, and cell-type-specific COMT overexpression in dopaminergic neurons produces motor impairment, providing a gain-of-function disease-relevant mechanism.","evidence":"iPSC-derived dopaminergic neurons and isogenic CRISPR PARK2 KO lines (RNA-seq, bisulfite sequencing); AAV-mediated COMT overexpression in DAT-Cre mice with motor behavioral testing","pmids":["31135049"],"confidence":"High","gaps":["Whether COMT upregulation is causal to neurodegeneration or a compensatory response is unresolved","Human in vivo confirmation of elevated COMT in PARK2 patient brains not shown"]},{"year":null,"claim":"The structural basis for how MB-COMT membrane tethering alters substrate selectivity and regioselectivity remains undefined, and whether COMT inhibition can be leveraged therapeutically for prefrontal cognitive deficits or preeclampsia in humans lacks clinical evidence.","evidence":"","pmids":[],"confidence":"Low","gaps":["No high-resolution structure of full-length MB-COMT in a membrane environment","Clinical trial data for COMT modulation in cognition or preeclampsia absent from the timeline","Cell-type-resolved COMT activity mapping across the full human brain not performed"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,1,5,7,13]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,1]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[2,13,17]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[2,13,17]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,1,5,9,15,16]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[3,4,14,15]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[4,19]}],"complexes":[],"partners":["ZNF804A","DTNBP1","MTHFR"],"other_free_text":[]},"mechanistic_narrative":"COMT is a magnesium- and S-adenosylmethionine-dependent O-methyltransferase that inactivates catecholamines (dopamine, norepinephrine) and catechol estrogens via O-methylation, expressed as soluble (S-COMT) and membrane-bound (MB-COMT) isoforms with MB-COMT predominating in human brain catecholamine metabolism at physiological substrate concentrations [PMID:11735324, PMID:11559542]. The common Val158Met polymorphism produces a 3–4-fold difference in catalytic activity and thermostability, and common synonymous haplotype variants further modulate enzyme output by altering mRNA stem-loop structure and translational efficiency, thereby governing prefrontal dopamine tone, pain sensitivity via the mu-opioid system, and homocysteine production through S-adenosylhomocysteine generation [PMID:8807664, PMID:17185601, PMID:12595695, PMID:18189241]. In the olfactory bulb, COMT rather than the dopamine transporter serves as the primary synaptic dopamine clearance mechanism, and cell-type-specific COMT overexpression in dopaminergic neurons produces catalepsy and motor impairment, while COMT-deficient mice exhibit altered stress-hormone responses, anxiety, and a preeclampsia-like phenotype rescued by the COMT product 2-methoxyestradiol [PMID:27445153, PMID:31135049, PMID:22192380, PMID:21304959]. COMT hemizygosity in 22q11.2 deletion syndrome halves mRNA, protein, and enzyme activity, and epistatic interactions with DTNBP1 genotype non-linearly modulate prefrontal working memory efficiency [PMID:23992923, PMID:24145376]."},"prefetch_data":{"uniprot":{"accession":"P21964","full_name":"Catechol O-methyltransferase","aliases":[],"length_aa":271,"mass_kda":30.0,"function":"Catalyzes the O-methylation, and thereby the inactivation, of catecholamine neurotransmitters and catechol hormones. Also shortens the biological half-lives of certain neuroactive drugs, like L-DOPA, alpha-methyl DOPA and isoproterenol","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P21964/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/COMT","classification":"Not Classified","n_dependent_lines":61,"n_total_lines":1208,"dependency_fraction":0.050496688741721855},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"VAPA","stoichiometry":0.2},{"gene":"CCDC47","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/COMT","total_profiled":1310},"omim":[{"mim_id":"621296","title":"CATECHOL-O-METHYLTRANSFERASE ACTIVITY, VARIATION IN","url":"https://www.omim.org/entry/621296"},{"mim_id":"619340","title":"DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 96; DEE96","url":"https://www.omim.org/entry/619340"},{"mim_id":"613290","title":"HEARING LOSS, CISPLATIN-INDUCED, SUSCEPTIBILITY TO; CIHL","url":"https://www.omim.org/entry/613290"},{"mim_id":"612414","title":"LEUCINE-RICH TRANSMEMBRANE O-METHYLTRANSFERASE; LRTOMT","url":"https://www.omim.org/entry/612414"},{"mim_id":"610778","title":"GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-1-LIKE; GNB1L","url":"https://www.omim.org/entry/610778"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Vesicles","reliability":"Enhanced"},{"location":"Endoplasmic reticulum","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/COMT"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P21964","domains":[{"cath_id":"3.40.50.150","chopping":"92-261","consensus_level":"high","plddt":97.7465,"start":92,"end":261}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P21964","model_url":"https://alphafold.ebi.ac.uk/files/AF-P21964-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P21964-F1-predicted_aligned_error_v6.png","plddt_mean":93.94},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=COMT","jax_strain_url":"https://www.jax.org/strain/search?query=COMT"},"sequence":{"accession":"P21964","fasta_url":"https://rest.uniprot.org/uniprotkb/P21964.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P21964/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P21964"}},"corpus_meta":[{"pmid":"12402217","id":"PMC_12402217","title":"A highly significant association between a COMT haplotype and schizophrenia.","date":"2002","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12402217","citation_count":553,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17805313","id":"PMC_17805313","title":"Catechol-O-methyltransferase (COMT): a gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders.","date":"2007","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17805313","citation_count":250,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16716201","id":"PMC_16716201","title":"The molecular genetics of cognition: dopamine, COMT and BDNF.","date":"2006","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/16716201","citation_count":235,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11559542","id":"PMC_11559542","title":"Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms.","date":"2001","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/11559542","citation_count":221,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16505837","id":"PMC_16505837","title":"The catechol-O-methyl transferase (COMT) gene as a candidate for psychiatric phenotypes: evidence and lessons.","date":"2006","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/16505837","citation_count":164,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10395222","id":"PMC_10395222","title":"Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism.","date":"1999","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/10395222","citation_count":144,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19446012","id":"PMC_19446012","title":"Genes, cognition and brain through a COMT lens.","date":"2009","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/19446012","citation_count":138,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15211633","id":"PMC_15211633","title":"COMT: a common susceptibility gene in bipolar disorder and schizophrenia.","date":"2004","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15211633","citation_count":124,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17978319","id":"PMC_17978319","title":"Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use.","date":"2007","source":"The British journal of psychiatry : the journal of mental science","url":"https://pubmed.ncbi.nlm.nih.gov/17978319","citation_count":124,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17412710","id":"PMC_17412710","title":"Is COMT a susceptibility gene for schizophrenia?","date":"2007","source":"Schizophrenia bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/17412710","citation_count":120,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15319576","id":"PMC_15319576","title":"COMT gene polymorphism is associated with declarative memory in adulthood and old age.","date":"2004","source":"Behavior genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15319576","citation_count":119,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22138198","id":"PMC_22138198","title":"Effects of COMT polymorphisms on brain function and behavior in health and disease.","date":"2011","source":"Brain research bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/22138198","citation_count":118,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19094200","id":"PMC_19094200","title":"Genetic variation in the catechol-O-methyltransferase (COMT) gene and morphine requirements in cancer patients with pain.","date":"2008","source":"Molecular pain","url":"https://pubmed.ncbi.nlm.nih.gov/19094200","citation_count":118,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17357147","id":"PMC_17357147","title":"Meta-analysis of COMT val158met in panic disorder: ethnic heterogeneity and gender specificity.","date":"2007","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17357147","citation_count":113,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12799619","id":"PMC_12799619","title":"Catechol O-methyltransferase (COMT) mRNA expression in the dorsolateral prefrontal cortex of patients with schizophrenia.","date":"2003","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12799619","citation_count":113,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22528689","id":"PMC_22528689","title":"Pain sensitivity in fibromyalgia is associated with catechol-O-methyltransferase (COMT) gene.","date":"2012","source":"European journal of pain (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/22528689","citation_count":103,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15817751","id":"PMC_15817751","title":"Catecholamines and aggression: the role of COMT and MAO polymorphisms.","date":"2004","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/15817751","citation_count":102,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19374521","id":"PMC_19374521","title":"Variation in the COMT gene: implications for pain perception and pain treatment.","date":"2009","source":"Pharmacogenomics","url":"https://pubmed.ncbi.nlm.nih.gov/19374521","citation_count":102,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19329282","id":"PMC_19329282","title":"Meta-analysis of association between genetic variants in COMT and schizophrenia: an update.","date":"2009","source":"Schizophrenia research","url":"https://pubmed.ncbi.nlm.nih.gov/19329282","citation_count":102,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12815746","id":"PMC_12815746","title":"Association analysis of MAOA and COMT with neuroticism assessed by peers.","date":"2003","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12815746","citation_count":94,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16483362","id":"PMC_16483362","title":"The quantification of COMT mRNA in post mortem cerebellum tissue: diagnosis, genotype, methylation and expression.","date":"2006","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16483362","citation_count":93,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21947654","id":"PMC_21947654","title":"Cannabis, COMT and psychotic experiences.","date":"2011","source":"The British journal of psychiatry : the journal of mental science","url":"https://pubmed.ncbi.nlm.nih.gov/21947654","citation_count":91,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23792050","id":"PMC_23792050","title":"The role of COMT gene variants in depression: Bridging neuropsychological, behavioral and clinical phenotypes.","date":"2013","source":"Neuroscience and biobehavioral reviews","url":"https://pubmed.ncbi.nlm.nih.gov/23792050","citation_count":90,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22384243","id":"PMC_22384243","title":"ZNF804a regulates expression of the schizophrenia-associated genes PRSS16, COMT, PDE4B, and DRD2.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22384243","citation_count":85,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25080080","id":"PMC_25080080","title":"Medicinal chemistry of catechol O-methyltransferase (COMT) inhibitors and their therapeutic utility.","date":"2014","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25080080","citation_count":82,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25320962","id":"PMC_25320962","title":"COMT haplotypes modulate associations of antenatal maternal anxiety and neonatal cortical morphology.","date":"2014","source":"The American journal of psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/25320962","citation_count":72,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15645182","id":"PMC_15645182","title":"Association of Ala72Ser polymorphism with COMT enzyme activity and the risk of schizophrenia in Koreans.","date":"2005","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15645182","citation_count":64,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30267599","id":"PMC_30267599","title":"Simultaneous regulation of F5H in COMT-RNAi transgenic switchgrass alters effects of COMT suppression on syringyl lignin biosynthesis.","date":"2018","source":"Plant biotechnology journal","url":"https://pubmed.ncbi.nlm.nih.gov/30267599","citation_count":64,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19290789","id":"PMC_19290789","title":"Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment.","date":"2009","source":"Pharmacogenomics","url":"https://pubmed.ncbi.nlm.nih.gov/19290789","citation_count":63,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16857316","id":"PMC_16857316","title":"The COMT val158met polymorphism and brain morphometry in healthy young adults.","date":"2006","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/16857316","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24145376","id":"PMC_24145376","title":"Epistatic interaction between COMT and DTNBP1 modulates prefrontal function in mice and in humans.","date":"2013","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/24145376","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17525973","id":"PMC_17525973","title":"Meta-analyses suggest association between COMT, but not HTR1B, alleles, and suicidal behavior.","date":"2007","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17525973","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23992923","id":"PMC_23992923","title":"Biological effects of COMT haplotypes and psychosis risk in 22q11.2 deletion syndrome.","date":"2013","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/23992923","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21695287","id":"PMC_21695287","title":"COMT genetic variants and pain.","date":"2011","source":"Drugs of today (Barcelona, Spain : 1998)","url":"https://pubmed.ncbi.nlm.nih.gov/21695287","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21471954","id":"PMC_21471954","title":"Sex modulates the associations between the COMT gene and personality traits.","date":"2011","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/21471954","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24343288","id":"PMC_24343288","title":"Effect of catechol-o-methyltransferase-gene (COMT) variants on experimental and acute postoperative pain in 1,000 women undergoing surgery for breast cancer.","date":"2013","source":"Anesthesiology","url":"https://pubmed.ncbi.nlm.nih.gov/24343288","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29281938","id":"PMC_29281938","title":"Pharmacophore-based virtual screening of catechol-o-methyltransferase (COMT) inhibitors to combat Alzheimer's disease.","date":"2017","source":"Journal of biomolecular structure & dynamics","url":"https://pubmed.ncbi.nlm.nih.gov/29281938","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35955626","id":"PMC_35955626","title":"Identification and Functional Analysis of the Caffeic Acid O-Methyltransferase (COMT) Gene Family in Rice (Oryza sativa L.).","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35955626","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22483293","id":"PMC_22483293","title":"The role of the catechol-O-methyltransferase (COMT) gene in personality and related psychopathological disorders.","date":"2012","source":"CNS & neurological disorders drug targets","url":"https://pubmed.ncbi.nlm.nih.gov/22483293","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11556837","id":"PMC_11556837","title":"Catechol-O-Methyltransferase (COMT) gene polymorphism and breast cancer risk in young women.","date":"2001","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/11556837","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20483479","id":"PMC_20483479","title":"Analysis of association between the catechol-O-methyltransferase (COMT) gene and negative symptoms in chronic schizophrenia.","date":"2010","source":"Psychiatry research","url":"https://pubmed.ncbi.nlm.nih.gov/20483479","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23907791","id":"PMC_23907791","title":"Role of COMT in ADHD: a systematic meta-analysis.","date":"2013","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/23907791","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21304959","id":"PMC_21304959","title":"Epistasis between COMT and MTHFR in maternal-fetal dyads increases risk for preeclampsia.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21304959","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26630958","id":"PMC_26630958","title":"The Role of the Catechol-o-Methyltransferase (COMT) GeneVal158Met in Aggressive Behavior, a Review of Genetic Studies.","date":"2015","source":"Current neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/26630958","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11121168","id":"PMC_11121168","title":"Association between homozygosity at the COMT gene locus and obsessive compulsive disorder.","date":"2000","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11121168","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10898900","id":"PMC_10898900","title":"No association between catechol-O-methyltransferase (COMT) gene polymorphism and attention deficit hyperactivity disorder (ADHD) in an Irish sample.","date":"2000","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10898900","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21095462","id":"PMC_21095462","title":"Toxicology and safety of COMT inhibitors.","date":"2010","source":"International review of neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/21095462","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28456872","id":"PMC_28456872","title":"Catechol-O-Methyltransferase (COMT): An Update on Its Role in Cancer, Neurological and Cardiovascular Diseases.","date":"2017","source":"Reviews of physiology, biochemistry and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28456872","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22483296","id":"PMC_22483296","title":"COMT as a drug target for cognitive functions and dysfunctions.","date":"2012","source":"CNS & neurological disorders drug targets","url":"https://pubmed.ncbi.nlm.nih.gov/22483296","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18189241","id":"PMC_18189241","title":"Polymorphisms in the catechol-O-methyltransferase (COMT) gene influence plasma total homocysteine levels.","date":"2008","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18189241","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20975619","id":"PMC_20975619","title":"Are genetic variants of COMT associated with addiction?","date":"2010","source":"Pharmacogenetics and genomics","url":"https://pubmed.ncbi.nlm.nih.gov/20975619","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26675825","id":"PMC_26675825","title":"Modification of COMT-dependent pain sensitivity by psychological stress and sex.","date":"2016","source":"Pain","url":"https://pubmed.ncbi.nlm.nih.gov/26675825","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10895397","id":"PMC_10895397","title":"The relationship between COMT genotype and the clinical effectiveness of tolcapone, a COMT inhibitor, in patients with Parkinson's disease.","date":"2000","source":"Clinical neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/10895397","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31335650","id":"PMC_31335650","title":"OPRM1 rs1799971, COMT rs4680, and FAAH rs324420 genes interact with placebo procedures to induce hypoalgesia.","date":"2019","source":"Pain","url":"https://pubmed.ncbi.nlm.nih.gov/31335650","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22784685","id":"PMC_22784685","title":"The COMT Met158 allele and violence in schizophrenia: a meta-analysis.","date":"2012","source":"Schizophrenia research","url":"https://pubmed.ncbi.nlm.nih.gov/22784685","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16414251","id":"PMC_16414251","title":"Is there an association between the COMT gene and P300 endophenotypes?","date":"2006","source":"European psychiatry : the journal of the Association of European Psychiatrists","url":"https://pubmed.ncbi.nlm.nih.gov/16414251","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10490696","id":"PMC_10490696","title":"Linkage disequilibrium on the COMT gene in French schizophrenics and controls.","date":"1999","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10490696","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11121178","id":"PMC_11121178","title":"Exploratory association study between catechol-O-methyltransferase (COMT) high/low enzyme activity polymorphism and hypnotizability.","date":"2000","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11121178","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21794324","id":"PMC_21794324","title":"[Relationship between COMT gene genotypes and severity of fibromyalgia].","date":"2008","source":"Reumatologia clinica","url":"https://pubmed.ncbi.nlm.nih.gov/21794324","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22100850","id":"PMC_22100850","title":"Complex estrogenic regulation of catechol-O-methyltransferase (COMT) in rats.","date":"2011","source":"Journal of physiology and pharmacology : an official journal of the Polish Physiological Society","url":"https://pubmed.ncbi.nlm.nih.gov/22100850","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17707921","id":"PMC_17707921","title":"Exploratory and habituation phenotype of heterozygous and homozygous COMT knockout mice.","date":"2007","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/17707921","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16648777","id":"PMC_16648777","title":"The association between high-activity COMT allele and alcoholism.","date":"2006","source":"Neuro endocrinology letters","url":"https://pubmed.ncbi.nlm.nih.gov/16648777","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17477346","id":"PMC_17477346","title":"Expression of multiple catechol-o-methyltransferase (COMT) mRNA variants in human brain.","date":"2007","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17477346","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26932718","id":"PMC_26932718","title":"Monoamine Oxidase A (MAOA) and Catechol-O-Methyltransferase (COMT) Gene Polymorphisms Interact with Maternal Parenting in Association with Adolescent Reactive Aggression but not Proactive Aggression: Evidence of Differential Susceptibility.","date":"2016","source":"Journal of youth and adolescence","url":"https://pubmed.ncbi.nlm.nih.gov/26932718","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25666727","id":"PMC_25666727","title":"Genetics and functional imaging: effects of APOE, BDNF, COMT, and KIBRA in aging.","date":"2015","source":"Neuropsychology review","url":"https://pubmed.ncbi.nlm.nih.gov/25666727","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28102561","id":"PMC_28102561","title":"Stressful life events and catechol-O-methyl-transferase (COMT) gene in bipolar disorder.","date":"2017","source":"Depression and anxiety","url":"https://pubmed.ncbi.nlm.nih.gov/28102561","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22192380","id":"PMC_22192380","title":"Physiological and behavioural responsivity to stress and anxiogenic stimuli in COMT-deficient mice.","date":"2011","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/22192380","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12884403","id":"PMC_12884403","title":"Tissue histopathology, clinical chemistry and behaviour of adult Comt-gene-disrupted mice.","date":"2003","source":"Journal of applied toxicology : JAT","url":"https://pubmed.ncbi.nlm.nih.gov/12884403","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21530215","id":"PMC_21530215","title":"Association of MAOA and COMT gene polymorphisms with palatable food intake in children.","date":"2011","source":"The Journal of nutritional biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21530215","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24107543","id":"PMC_24107543","title":"Genetic influence of COMT and BDNF gene polymorphisms on resilience in healthy college students.","date":"2013","source":"Neuropsychobiology","url":"https://pubmed.ncbi.nlm.nih.gov/24107543","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17295924","id":"PMC_17295924","title":"Breast density and polymorphisms in genes coding for CYP1A2 and COMT: the Multiethnic Cohort.","date":"2007","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/17295924","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11735324","id":"PMC_11735324","title":"Catecholamine metabolism in the brain by membrane-bound and soluble catechol-o-methyltransferase (COMT) estimated by enzyme kinetic values.","date":"2001","source":"Medical hypotheses","url":"https://pubmed.ncbi.nlm.nih.gov/11735324","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24782743","id":"PMC_24782743","title":"Association of COMT and COMT-DRD2 interaction with creative potential.","date":"2014","source":"Frontiers in human neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/24782743","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28085950","id":"PMC_28085950","title":"Impact of DRD2/ANKK1 and COMT Polymorphisms on Attention and Cognitive Functions in Schizophrenia.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28085950","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8950414","id":"PMC_8950414","title":"Identification of a BglI polymorphism of catechol-O-methyltransferase (COMT) gene, and association study with schizophrenia.","date":"1996","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8950414","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12956522","id":"PMC_12956522","title":"Structure of the tobacco caffeic acid O-methyltransferase (COMT) II gene: identification of promoter sequences involved in gene inducibility by various stimuli.","date":"2003","source":"Plant molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12956522","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30130297","id":"PMC_30130297","title":"The opioid receptor mu 1 (OPRM1) rs1799971 and catechol-O-methyltransferase (COMT) rs4680 as genetic markers for placebo analgesia.","date":"2018","source":"Pain","url":"https://pubmed.ncbi.nlm.nih.gov/30130297","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18063308","id":"PMC_18063308","title":"Association of DRD4 and COMT polymorphisms with anger and forgiveness traits in healthy volunteers.","date":"2007","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/18063308","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19721400","id":"PMC_19721400","title":"Association between COMT gene and Chinese male schizophrenic patients with violent behavior.","date":"2009","source":"Medical science monitor : international medical journal of experimental and clinical research","url":"https://pubmed.ncbi.nlm.nih.gov/19721400","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29248857","id":"PMC_29248857","title":"Catechol-O-methyltransferase (COMT) genotype affects cognitive control during total sleep deprivation.","date":"2017","source":"Cortex; a journal devoted to the study of the nervous system and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/29248857","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24431998","id":"PMC_24431998","title":"Hypnotizability and Catechol-O-Methyltransferase (COMT) polymorphysms in Italians.","date":"2014","source":"Frontiers in human neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/24431998","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28315782","id":"PMC_28315782","title":"Human COMT over-expression confers a heightened susceptibility to dyskinesia in mice.","date":"2017","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/28315782","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21934638","id":"PMC_21934638","title":"A COMT gene haplotype associated with methamphetamine abuse.","date":"2011","source":"Pharmacogenetics and genomics","url":"https://pubmed.ncbi.nlm.nih.gov/21934638","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21656904","id":"PMC_21656904","title":"Association between polymorphisms in catechol-O-methyltransferase (COMT) and cocaine-induced paranoia in European-American and African-American populations.","date":"2011","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21656904","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30218069","id":"PMC_30218069","title":"Catechol-O-methyltransferase (COMT) genotypes are associated with varying soluble, but not membrane-bound COMT protein in the human prefrontal cortex.","date":"2018","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30218069","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9633684","id":"PMC_9633684","title":"Extending levodopa action: COMT inhibition.","date":"1998","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/9633684","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28205449","id":"PMC_28205449","title":"Variations in COMT and NTRK2 Influence Symptom Burden in Women Undergoing Breast Cancer Treatment.","date":"2017","source":"Biological research for nursing","url":"https://pubmed.ncbi.nlm.nih.gov/28205449","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31135049","id":"PMC_31135049","title":"Cell-specific overexpression of COMT in dopaminergic neurons of Parkinson's disease.","date":"2019","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/31135049","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23785672","id":"PMC_23785672","title":"Genetic polymorphisms in CYP1A1, CYP1B1 and COMT genes in Greenlandic Inuit and Europeans.","date":"2013","source":"International journal of circumpolar health","url":"https://pubmed.ncbi.nlm.nih.gov/23785672","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27445153","id":"PMC_27445153","title":"Subsecond Regulation of Synaptically Released Dopamine by COMT in the Olfactory Bulb.","date":"2016","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/27445153","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23034259","id":"PMC_23034259","title":"Association analysis of dopaminergic gene variants (Comt, Drd4 And Dat1) with Alzheimer s disease.","date":"2012","source":"Journal of biological regulators and homeostatic agents","url":"https://pubmed.ncbi.nlm.nih.gov/23034259","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31124409","id":"PMC_31124409","title":"Systems pharmacogenomics - gene, disease, drug and placebo interactions: a case study in COMT.","date":"2019","source":"Pharmacogenomics","url":"https://pubmed.ncbi.nlm.nih.gov/31124409","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17173666","id":"PMC_17173666","title":"Lack of association between COMT gene and deficit/nondeficit schizophrenia.","date":"2006","source":"Behavioral and brain functions : BBF","url":"https://pubmed.ncbi.nlm.nih.gov/17173666","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23178897","id":"PMC_23178897","title":"The catechol-O-methyltransferase gene (COMT) and cognitive function from childhood through adolescence.","date":"2012","source":"Biological psychology","url":"https://pubmed.ncbi.nlm.nih.gov/23178897","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28728097","id":"PMC_28728097","title":"Nonlinear modulation of interacting between COMT and depression on brain function.","date":"2017","source":"European psychiatry : the journal of the Association of European Psychiatrists","url":"https://pubmed.ncbi.nlm.nih.gov/28728097","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33716157","id":"PMC_33716157","title":"Brain predictive coding processes are associated to COMT gene Val158Met polymorphism.","date":"2021","source":"NeuroImage","url":"https://pubmed.ncbi.nlm.nih.gov/33716157","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29439855","id":"PMC_29439855","title":"Catechol-O-methyltransferase (COMT) genetic variants are associated with cognitive decline in patients with Parkinson's disease.","date":"2018","source":"Parkinsonism & related disorders","url":"https://pubmed.ncbi.nlm.nih.gov/29439855","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31285095","id":"PMC_31285095","title":"Evaluation of genetic risk related to catechol-O-methyltransferase (COMT) and β2-adrenergic receptor (ADRB2) activity in different diagnostic subgroups of temporomandibular disorder in Brazilian patients.","date":"2019","source":"International journal of oral and maxillofacial surgery","url":"https://pubmed.ncbi.nlm.nih.gov/31285095","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18752908","id":"PMC_18752908","title":"The catechol-O-methyltransferase (COMT) gene polymorphism and prevalence of uterine fibroids.","date":"2008","source":"Maturitas","url":"https://pubmed.ncbi.nlm.nih.gov/18752908","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21217836","id":"PMC_21217836","title":"No Association Between Functional Polymorphisms in COMT and MTHFR and Schizophrenia Risk in Korean Population.","date":"2010","source":"Epidemiology and health","url":"https://pubmed.ncbi.nlm.nih.gov/21217836","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32353859","id":"PMC_32353859","title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32353859","citation_count":3411,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16189514","id":"PMC_16189514","title":"Towards a proteome-scale map of the human protein-protein interaction network.","date":"2005","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/16189514","citation_count":2090,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11381111","id":"PMC_11381111","title":"Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia.","date":"2001","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11381111","citation_count":1868,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16169070","id":"PMC_16169070","title":"A human protein-protein interaction network: a resource for annotating the proteome.","date":"2005","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16169070","citation_count":1704,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8807664","id":"PMC_8807664","title":"Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders.","date":"1996","source":"Pharmacogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/8807664","citation_count":1447,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10391209","id":"PMC_10391209","title":"Characterization of single-nucleotide polymorphisms in coding regions of human genes.","date":"1999","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10391209","citation_count":1381,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"24816252","id":"PMC_24816252","title":"An atlas of genetic influences on human blood metabolites.","date":"2014","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24816252","citation_count":1209,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25416956","id":"PMC_25416956","title":"A proteome-scale map of the human interactome network.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25416956","citation_count":977,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15537663","id":"PMC_15537663","title":"Genetic basis for individual variations in pain perception and the development of a chronic pain condition.","date":"2004","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15537663","citation_count":911,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12595695","id":"PMC_12595695","title":"COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor.","date":"2003","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/12595695","citation_count":852,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18583979","id":"PMC_18583979","title":"Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database.","date":"2008","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18583979","citation_count":817,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15866551","id":"PMC_15866551","title":"Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction.","date":"2005","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/15866551","citation_count":804,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19812213","id":"PMC_19812213","title":"The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort.","date":"2009","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/19812213","citation_count":724,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19506906","id":"PMC_19506906","title":"Candidate gene studies of ADHD: a meta-analytic review.","date":"2009","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19506906","citation_count":713,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17185601","id":"PMC_17185601","title":"Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure.","date":"2006","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/17185601","citation_count":686,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19060904","id":"PMC_19060904","title":"An empirical framework for binary interactome mapping.","date":"2008","source":"Nature methods","url":"https://pubmed.ncbi.nlm.nih.gov/19060904","citation_count":652,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19056867","id":"PMC_19056867","title":"Large-scale proteomics and phosphoproteomics of urinary exosomes.","date":"2008","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/19056867","citation_count":607,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22190034","id":"PMC_22190034","title":"Global landscape of HIV-human protein complexes.","date":"2011","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/22190034","citation_count":593,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33060197","id":"PMC_33060197","title":"Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.","date":"2020","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/33060197","citation_count":564,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16476412","id":"PMC_16476412","title":"Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond.","date":"2006","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/16476412","citation_count":550,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33845483","id":"PMC_33845483","title":"Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/33845483","citation_count":532,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12963670","id":"PMC_12963670","title":"Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia.","date":"2003","source":"Archives of general psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/12963670","citation_count":488,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11925305","id":"PMC_11925305","title":"A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition.","date":"2002","source":"The American journal of psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/11925305","citation_count":463,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":46385,"output_tokens":4714,"usd":0.104932},"stage2":{"model":"claude-opus-4-6","input_tokens":8185,"output_tokens":3756,"usd":0.202237},"total_usd":0.629363,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":58516,"output_tokens":6284,"usd":0.134904},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":9147,"output_tokens":3165,"usd":0.18729}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2001,\n      \"finding\": \"Recombinant wild-type (Val108) and variant (Met108) COMT were expressed, purified, and assayed in vitro for methylation of catechol estrogens (2-OHE2, 4-OHE2, 2-OHE1, 4-OHE1). The Met108 variant isoform is thermolabile and shows 2–3-fold lower catalytic activity than wild-type Val108 COMT, resulting in reduced methoxy estrogen formation. For 2-hydroxylated substrates, methylation occurs at both 2-OH and 3-OH positions; for 4-hydroxylated substrates, only at the 4-OH group. Order of product formation: 4-MeOE2 > 4-MeOE1 >> 2-MeOE2 > 2-MeOE1.\",\n      \"method\": \"In vitro enzymatic assay with recombinant His-tagged proteins purified by Ni-NTA chromatography; GC/MS quantitation of methoxy products; cell-line validation with MCF-7 (Met/Met) vs ZR-75 (Val/Val)\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro with purified recombinant protein, multiple substrates tested, validated in cell lines\",\n      \"pmids\": [\"11559542\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"A kinetic model using published Km/Vmax values of recombinant MB-COMT and S-COMT demonstrates that MB-COMT predominates the O-methylation of dopamine and noradrenaline in human brain (where MB-COMT represents ~70% of total COMT protein), whereas S-COMT predominates in rat brain (~30% MB-COMT). The meta/para product ratio is higher for MB-COMT than S-COMT.\",\n      \"method\": \"Enzyme kinetic modelling using published in vitro Km and Vmax values for recombinant MB-COMT and S-COMT isoforms\",\n      \"journal\": \"Medical hypotheses\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 method (enzyme kinetics) but single computational/modelling study without direct experimental validation in brain tissue\",\n      \"pmids\": [\"11735324\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"COMT mRNA expression in the dorsolateral prefrontal cortex (DLPFC) shows a disease-related laminar distribution change in schizophrenia: lower levels in superficial layers (II/III) and higher levels in intermediate/deep layers (IV/V) relative to controls. Neither mean level nor laminar distribution was related to the Val158Met genotype, suggesting mRNA-level feedback compensation does not explain the polymorphism's functional effect.\",\n      \"method\": \"In situ hybridization histochemistry on post-mortem DLPFC; genotyping for Val158Met\",\n      \"journal\": \"Neuropsychopharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization/expression experiment in human brain tissue, single study\",\n      \"pmids\": [\"12799619\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The Ala72Ser (rs6267) coding polymorphism of COMT, causing an alanine-to-serine substitution at codon 22/72 (S-COMT/MB-COMT numbering), is correlated with reduced COMT enzyme activity and is associated with increased schizophrenia risk in Koreans, independent of the Val158Met effect.\",\n      \"method\": \"Case-control genotyping (320 patients, 379 controls); enzyme activity measurement correlated with Ala72Ser genotype\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct enzyme activity measurement linked to genotype, single study\",\n      \"pmids\": [\"15645182\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"COMT mRNA expression in human post-mortem cerebellum is influenced by genotype: the Val158Met Val allele (rs4680), rs737865 G allele, and rs165599 G allele are each associated with reduced COMT gene expression. A strong sexual dimorphism was found, with females exhibiting significantly greater COMT mRNA levels.\",\n      \"method\": \"Quantitative RT-PCR on 60 post-mortem cerebellum samples; methylation analysis of promoter CpG sites; genotyping\",\n      \"journal\": \"BMC medical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — quantitative mRNA measurement linked to specific SNPs and sex, single study\",\n      \"pmids\": [\"16483362\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Multiple variant COMT mRNAs are expressed in human frontal cortex, arising from insertions and deletions within the known COMT brain transcript. At least seven variant mRNAs were detected, several altering the predicted coding sequence, revealing additional complexity beyond the single previously described brain transcript encoding MB-COMT and S-COMT.\",\n      \"method\": \"RT-PCR with intron-spanning primers; sequencing of amplicons; regional distribution analysis in human brain\",\n      \"journal\": \"American journal of medical genetics. Part B, Neuropsychiatric genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct RT-PCR identification and sequencing of novel transcripts in human brain, single study\",\n      \"pmids\": [\"17477346\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"High-activity COMT Val158 carriers have significantly higher plasma total homocysteine (tHcy) than Met158 homozygotes, consistent with increased SAH production by COMT activity. This effect is limited to individuals homozygous for the low-activity MTHFR T677 allele, demonstrating epistatic interaction between COMT and MTHFR in controlling homocysteine levels.\",\n      \"method\": \"Genotyping of 780 community-dwelling elderly subjects for COMT Val158Met and A(-287)G, and MTHFR C677T; plasma tHcy measurement\",\n      \"journal\": \"American journal of medical genetics. Part B, Neuropsychiatric genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct biochemical measurement (plasma tHcy) linked to COMT genotype with epistasis analysis, single study\",\n      \"pmids\": [\"18189241\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"In the olfactory bulb (OB), COMT is the predominant mechanism for dopamine (DA) clearance rather than dopamine transporter (DAT) re-uptake. The OB contains ~50% more COMT per unit tissue than striatum and dramatically less DAT. Pharmacological blockade of COMT with tolcapone increased optogenetically evoked DA signals ~2-fold by fast-scan cyclic voltammetry, while the DAT inhibitor GBR12909 had no effect.\",\n      \"method\": \"Quantitative COMT and DAT protein measurement (tissue comparison); optogenetics (ChR2 in TH+ neurons); fast-scan cyclic voltammetry; pharmacological COMT inhibition with tolcapone\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods (voltammetry, optogenetics, pharmacology, protein quantification) in same study establishing COMT as the primary DA clearance mechanism in OB\",\n      \"pmids\": [\"27445153\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Catechol-O-methyltransferase (Comt)-deficient pregnant mice develop a preeclampsia-like phenotype reversible by exogenous 2-methoxyestradiol (2-ME), demonstrating that COMT-generated 2-ME inhibits HIF-1α, a transcription factor mediating hypoxic responses in the placenta.\",\n      \"method\": \"Comt knockout mouse model; rescue experiment with 2-methoxyestradiol; HIF-1α pathway analysis; human genetic association study (COMT haplotypes × MTHFR in 1103 Chilean dyads)\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — KO mouse phenotype with specific biochemical rescue, plus mechanistic pathway (HIF-1α inhibition by 2-ME), replicated in human genetic data\",\n      \"pmids\": [\"21304959\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"ZNF804a directly binds chromatin proximal to the COMT promoter (confirmed by ChIP with both epitope-tagged and endogenous ZNF804a) and upregulates COMT transcript levels, establishing ZNF804a as a direct transcriptional activator of COMT.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) with endogenous and tagged ZNF804a; overexpression in rat neural progenitor cells; quantitative RT-PCR; immunocytochemistry for nuclear localization\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal ChIP with endogenous protein plus functional mRNA quantification, single study\",\n      \"pmids\": [\"22384243\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Genetic reduction of COMT alone in mice improves working memory, but co-reduction of both COMT and DTNBP1 (dysbindin) in the same mouse produces working memory deficits, demonstrating a non-linear epistatic interaction between these two genes in prefrontal cortical dopamine signaling and cognition. The same non-linear interaction was observed in human fMRI data (N=176).\",\n      \"method\": \"Genetic epistasis in double-mutant mice (COMT × DTNBP1 reduction); working memory behavioral testing; human fMRI neuroimaging during working memory paradigm with COMT/DTNBP1 genotyping\",\n      \"journal\": \"Molecular psychiatry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — mouse double-mutant epistasis with behavioral readout replicated in human neuroimaging, two orthogonal systems\",\n      \"pmids\": [\"24145376\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"In 22q11.2 deletion syndrome (hemizygous for COMT), lymphoblast samples show ~50% reduction in COMT mRNA, protein, and enzyme activity. Haplotype analysis reveals that the G variant of rs165599 (3'UTR SNP) is associated with low COMT expression, psychosis, and lower performance IQ. The rs74745580 'T' mutation is associated with absent soluble COMT (S-COMT) expression and very low enzyme activity.\",\n      \"method\": \"Direct measurement of COMT mRNA, protein (Western blot), and enzyme activity in lymphoblasts from 22q11.2DS subjects; haplotype analysis; structured clinical assessment\",\n      \"journal\": \"Biological psychiatry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct protein/mRNA/activity measurements across haplotypes in human samples, multiple orthogonal measurements, single study\",\n      \"pmids\": [\"23992923\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Human COMT overexpression in transgenic mice lowers basal striatal dopamine levels, exacerbates l-DOPA-induced dyskinesia without altering motor efficacy, and increases the DA metabolite 3-methoxytyramine in the lesioned striatum, along with potentiated FosB and phospho-acetylated histone 3 induction. This demonstrates that elevated COMT activity degrades dopamine and l-DOPA to heighten dyskinesia susceptibility.\",\n      \"method\": \"Transgenic mice overexpressing human COMT; unilateral 6-OHDA striatal lesion; chronic l-DOPA treatment; dyskinesia scoring; neurochemical (HPLC for dopamine and metabolites) and molecular (immunohistochemistry for FosB, H3 phospho-acetylation) analyses\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — transgenic overexpression with specific phenotypic and neurochemical readouts, multiple orthogonal assays in single study\",\n      \"pmids\": [\"28315782\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"COMT genotypes at rs4680 (Val158Met) and rs4818, but not rs737865 or rs165599, are independently associated with varying levels of soluble COMT (S-COMT) protein, but not membrane-bound COMT (MB-COMT), in human post-mortem prefrontal cortex. This indicates that these SNPs regulate S-COMT protein abundance, which may underlie genotype effects on cognition.\",\n      \"method\": \"Western blot quantification of S-COMT and MB-COMT protein in prefrontal cortex from 199 post-mortem subjects; genotyping for four COMT SNPs\",\n      \"journal\": \"Journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct protein quantification in human brain tissue linked to specific SNPs, single study\",\n      \"pmids\": [\"30218069\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"COMT expression is dramatically increased and promoter DNA hypomethylated in iPSC-derived dopaminergic neurons from Parkinson's disease patients with PARK2 (parkin) mutations and in isogenic PARK2-KO iPSC lines. Overexpression of COMT specifically in dopaminergic neurons (DAT-Cre mice) produces cataleptic behaviours and impaired motor coordination, demonstrating that elevated COMT activity in dopaminergic neurons is sufficient to cause dopaminergic dysfunction.\",\n      \"method\": \"iPSC-derived dopaminergic neurons from PARK2 patients and CRISPR-Cas9 isogenic controls; bisulfite sequencing (DNA methylation); cell-type-specific viral COMT overexpression in DAT-Cre mice; behavioral phenotyping\",\n      \"journal\": \"Brain\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — iPSC disease model with isogenic controls, CRISPR validation, and in vivo cell-type-specific overexpression with defined motor phenotype\",\n      \"pmids\": [\"31135049\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Female COMT knockout mice display increased corticosterone response to acute (but not chronic) stress, a modified cytokine profile after chronic stress, and increased anxiety behavior. COMT KO genotype alters sensitivity to benzodiazepines, and acute tolcapone (COMT inhibitor) decreases benzodiazepine sensitivity in WT mice, linking COMT enzyme activity to anxiolytic drug action.\",\n      \"method\": \"COMT KO mice; serum corticosterone and cytokine measurement; light-dark anxiety test; pharmacological challenge with midazolam, chlordiazepoxide, and tolcapone\",\n      \"journal\": \"Behavioural brain research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO plus pharmacological inhibition with specific neuroendocrine and behavioral readouts, single study\",\n      \"pmids\": [\"22192380\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Complex estrogenic regulation of COMT activity and protein expression was demonstrated in rats in vivo: estradiol downregulates COMT protein in the prefrontal cortex and kidneys but doubles COMT protein in the prostate; tamoxifen increases COMT protein in several central and peripheral tissues. COMT activity was relatively resistant to these manipulations, and effects were sex- and tissue-dependent.\",\n      \"method\": \"In vivo rat treatment with estradiol or tamoxifen; COMT activity assay and Western blot protein quantification in multiple brain and peripheral tissues; ovariectomy model\",\n      \"journal\": \"Journal of physiology and pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct COMT activity and protein measurement across tissues and hormonal manipulations in vivo, single study\",\n      \"pmids\": [\"22100850\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"COMT is a Mg2+-dependent methyltransferase that uses SAM as cofactor to O-methylate catechol substrates including dopamine, norepinephrine, epinephrine, catechol estrogens, and l-DOPA; it exists as membrane-bound (MB-COMT) and soluble (S-COMT) isoforms encoded by alternate transcripts, with MB-COMT predominating dopamine/norepinephrine inactivation in human brain and being the primary DA clearance mechanism in the olfactory bulb over DAT re-uptake; the common Val158Met polymorphism reduces S-COMT thermostability and protein levels, lowering enzymatic activity and thereby elevating prefrontal dopamine, while additional coding (Ala72Ser) and regulatory (rs165599, rs737865) variants further modulate enzyme activity; COMT-generated 2-methoxyestradiol suppresses HIF-1α signaling, COMT transcription is directly activated by ZNF804a, estrogens downregulate COMT in prefrontal cortex, and PARK2 loss causes COMT upregulation via DNA hypomethylation in dopaminergic neurons, with COMT overexpression in those neurons sufficient to impair motor function.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll classify each paper first, then extract mechanistic discoveries only from KEEP papers.\n\n**Classification notes:**\n- Papers [28] (Plant COMT/switchgrass), [38] (Rice COMT), [76] (Tobacco COMT II) → EXCLUDE: plant caffeic acid O-methyltransferase, symbol collision\n- Additional papers [1-13, 15-24, 26, 29-30] (SARS-CoV-2, interactome maps, MGC, GO, etc.) → EXCLUDE: not about COMT gene\n- All remaining papers about human/mammalian COMT → classify for mechanistic content\n\n**Mechanistic KEEP papers** (with direct experimental findings about HOW COMT works):\n- PMID:11559542: Enzymatic activity of wild-type vs. variant COMT on catechol estrogens\n- PMID:8807664: Functional polymorphism Val158Met causing 3-4x variation in enzyme activity\n- PMID:11381111: COMT Val158Met effects on dopamine catabolism, prefrontal cognition, fMRI\n- PMID:15537663: COMT haplotypes determine enzymatic activity and pain sensitivity; COMT inhibition in rats increases pain sensitivity\n- PMID:17185601: mRNA secondary structure underlies haplotype differences in COMT protein levels/activity\n- PMID:12595695: COMT Val158Met affects mu-opioid neurotransmitter responses to pain\n- PMID:11735324: Kinetic model of MB-COMT vs S-COMT isoforms in brain catecholamine metabolism\n- PMID:27445153: COMT is primary mechanism for dopamine clearance in olfactory bulb (optogenetics + voltammetry)\n- PMID:17477346: Multiple COMT mRNA variants in human brain\n- PMID:24145376: Epistatic interaction between COMT and DTNBP1 on prefrontal function (mouse KO + human fMRI)\n- PMID:22384243: ZNF804a transcription factor directly binds COMT promoter and upregulates COMT expression\n- PMID:23992923: COMT hemizygosity → ~50% reduction in mRNA, protein, enzyme activity; haplotype effects on isoform expression\n- PMID:22100850: Estrogen regulation of COMT activity in rats (sex/tissue dependent)\n- PMID:30218069: COMT SNPs rs4680/rs4818 associated with varying S-COMT but not MB-COMT protein in prefrontal cortex\n- PMID:15645182: Ala72Ser substitution reduces COMT enzyme activity\n- PMID:28315782: COMT overexpression in mice reduces striatal dopamine, exacerbates L-DOPA dyskinesia\n- PMID:31135049: COMT overexpression in dopaminergic neurons (iPSC-derived, PARK2 model) leads to motor dysfunction\n- PMID:18189241: High-activity COMT Val158 increases homocysteine (via SAH production), interacts with MTHFR\n- PMID:12799619: Laminar pattern of COMT mRNA expression differs in schizophrenia DLPFC\n- PMID:16483362: COMT SNPs influence mRNA expression; sexual dimorphism in COMT expression\n- PMID:21304959: COMT activity linked to 2-methoxyestradiol/HIF-1α pathway; COMT deficiency produces preeclampsia phenotype reversed by 2-ME\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"A G→A transition at codon 158 of the COMT gene (Val158Met) causes a 3- to 4-fold variation in COMT enzyme activity; the Met158 allele encodes a thermolabile, low-activity enzyme, while Val158 encodes a high-activity, thermostable form.\",\n      \"method\": \"PCR-RFLP genotyping combined with enzyme activity assays in human red blood cells and lymphocytes\",\n      \"journal\": \"Pharmacogenetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct biochemical assay establishing catalytic consequences of variant; replicated extensively across labs\",\n      \"pmids\": [\"8807664\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Recombinant wild-type COMT (108Val) and variant COMT (108Met) differ in catechol estrogen methylation: the Met variant is thermolabile and shows 2-3-fold lower catalytic activity toward 2-OHE2, 4-OHE2, 2-OHE1, and 4-OHE1. Methylation of 4-OH catechol estrogens occurs only at the 4-OH group, while 2-OH catechol estrogens are methylated at both 2-OH and 3-OH positions.\",\n      \"method\": \"Recombinant His-tagged COMT isoforms purified by nickel chromatography; GC/MS quantitation of methoxy products; comparison with MCF-7 and ZR-75 breast cancer cell lines with matched genotypes\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro enzyme assay with purified recombinant proteins and orthogonal cell-based validation\",\n      \"pmids\": [\"11559542\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"A kinetic model using published Km/Vmax values of recombinant MB-COMT and S-COMT indicates that in human brain, where MB-COMT constitutes ~70% of total COMT protein, MB-COMT predominates in the O-methylation of dopamine and noradrenaline at low (physiological) concentrations; in rat brain (MB-COMT ~30%), S-COMT predominates for L-DOPA and 3,4-dihydroxybenzoic acid. The meta/para product ratio is higher for MB-COMT than S-COMT.\",\n      \"method\": \"Enzyme kinetic modeling using published in vitro Km/Vmax values for recombinant isoforms combined with published tissue composition data\",\n      \"journal\": \"Medical hypotheses\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 kinetic data but derived from computational modeling, not direct experiment in intact tissue\",\n      \"pmids\": [\"11735324\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"COMT Val158Met genotype predicts prefrontal cognitive performance (Wisconsin Card Sorting Test perseverative errors) in an allele-dosage fashion, with Met allele load associated with better executive function; COMT Val158Met also predicts efficiency of prefrontal cortical physiological response during working memory measured by fMRI; Val allele transmission was increased in schizophrenia trios.\",\n      \"method\": \"Neuropsychological testing + fMRI during working memory task in patients, siblings and controls stratified by COMT genotype; family-based transmission disequilibrium test\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — convergent evidence from behavioral, neuroimaging, and genetic transmission analyses across large cohorts; highly cited foundational study\",\n      \"pmids\": [\"11381111\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"COMT Val158Met genotype modulates mu-opioid neurotransmitter responses to sustained pain: Met158 homozygotes show diminished regional mu-opioid system activation (measured by PET with [11C]carfentanil), higher sensory and affective pain ratings, and more negative affect; Val158 homozygotes show opposite effects.\",\n      \"method\": \"PET neuroimaging with mu-opioid receptor radioligand [11C]carfentanil during sustained experimental pain, stratified by COMT Val158Met genotype\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct in vivo neurochemical measurement (receptor binding/occupancy) linking COMT genotype to endogenous opioid system function\",\n      \"pmids\": [\"12595695\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Three common COMT haplotypes (LPS, APS, HPS), defined by combinations of synonymous and one nonsynonymous SNP, determine COMT enzymatic activity inversely correlating with pain sensitivity. The LPS haplotype produces the highest enzymatic activity and is associated with reduced risk of temporomandibular disorder. Pharmacological inhibition of COMT in rats produces a profound increase in pain sensitivity.\",\n      \"method\": \"Haplotype analysis in human cohorts; COMT enzyme activity assays; rat model with COMT inhibitor administration and behavioral pain testing\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — combines human genetic haplotype/enzyme activity data with direct pharmacological intervention in animal model, multiple orthogonal methods\",\n      \"pmids\": [\"15537663\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The Ala72Ser substitution in COMT (rs6267; codon 22/72 in soluble/membrane-bound form respectively) reduces COMT enzyme activity and is associated with increased schizophrenia risk in Koreans, while the Val158Met polymorphism was not associated in this population.\",\n      \"method\": \"Enzyme activity assays in lymphocyte samples stratified by Ala72Ser genotype; case-control association study (320 patients, 379 controls)\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct enzyme activity measurement linked to coding variant; single population study\",\n      \"pmids\": [\"15645182\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Three common COMT haplotypes that differ at two synonymous positions (in addition to Val158Met) produce the largest differences in enzymatic activity primarily due to differences in the amount of translated protein. These synonymous variants alter mRNA local stem-loop secondary structure; more stable stem-loops correlate with lower protein levels and lower enzymatic activity. Site-directed mutagenesis eliminating the stable stem-loop structure restores translated protein levels.\",\n      \"method\": \"Luciferase reporter assays with COMT haplotype constructs; quantitative Western blotting; computational RNA secondary structure prediction; site-directed mutagenesis\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with reporters, mutagenesis rescue, and structural prediction converge on a single mechanism\",\n      \"pmids\": [\"17185601\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Multiple COMT variant mRNAs are expressed in human frontal cortex, resulting from insertions and deletions within the known brain transcript; several alter the predicted coding sequence. These variants are differentially distributed across brain regions.\",\n      \"method\": \"RT-PCR with intron-spanning primers across all exon-to-exon combinations; sequencing confirmation; regional RT-PCR characterization\",\n      \"journal\": \"American journal of medical genetics. Part B, Neuropsychiatric genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct molecular characterization of transcript variants; single lab, functional consequences not fully defined\",\n      \"pmids\": [\"17477346\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"High-activity COMT Val158 carriers have significantly higher plasma total homocysteine levels than Met158 homozygotes, an effect limited to individuals homozygous for the MTHFR T677 allele. This demonstrates that COMT activity influences homocysteine metabolism via generation of S-adenosylhomocysteine (SAH), a homocysteine precursor, and shows interaction with the SAM-regenerating enzyme MTHFR.\",\n      \"method\": \"Plasma total homocysteine measurement in 780 elderly individuals stratified by COMT Val158Met and MTHFR C677T genotypes; interaction analysis\",\n      \"journal\": \"American journal of medical genetics. Part B, Neuropsychiatric genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — links COMT catalytic activity to a defined biochemical pathway (SAH/homocysteine) in vivo; single study but mechanistically coherent\",\n      \"pmids\": [\"18189241\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Estrogen regulates COMT activity in a sex- and tissue-dependent manner in rats: estradiol down-regulates COMT protein in prefrontal cortex and kidneys but doubles COMT protein in prostate; tamoxifen (estrogen antagonist) increases COMT protein in multiple central and peripheral tissues. COMT activity does not always parallel COMT protein levels.\",\n      \"method\": \"In vivo estradiol and tamoxifen treatment of male/female/ovariectomized Wistar rats; COMT enzyme activity assays and COMT protein quantification in multiple tissues\",\n      \"journal\": \"Journal of physiology and pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct pharmacological manipulation in vivo with both activity and protein measurements; single study\",\n      \"pmids\": [\"22100850\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"COMT-deficient (knockout) mice show increased corticosterone response to acute but not chronic restraint stress, and a modified cytokine profile after chronic but not acute stress. Female COMT KO mice display increased anxiety behavior and altered benzodiazepine sensitivity, indicating COMT modulates stress-related hormonal and immune parameters in a stressor-chronicity-dependent manner.\",\n      \"method\": \"COMT KO mice (heterozygous and homozygous); serum corticosterone and cytokine measurement after acute vs. chronic restraint; light-dark anxiety test with benzodiazepine administration\",\n      \"journal\": \"Behavioural brain research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function with defined neuroendocrine phenotypic readouts; single lab\",\n      \"pmids\": [\"22192380\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"ZNF804a, a C2H2 zinc-finger transcription factor, directly binds chromatin proximal to the COMT promoter region and upregulates COMT transcript levels. Chromatin immunoprecipitation (ChIP) demonstrated both epitope-tagged and endogenous ZNF804a interaction with COMT promoter sequences.\",\n      \"method\": \"ZNF804a overexpression with quantitative RT-PCR for COMT mRNA; chromatin immunoprecipitation (ChIP) with both tagged and endogenous ZNF804a; immunocytochemistry confirming nuclear localization in rat neural progenitors\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal ChIP with endogenous and tagged protein plus functional mRNA quantification; single lab\",\n      \"pmids\": [\"22384243\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"COMT hemizygosity in 22q11.2 deletion syndrome results in approximately 50% reduction in COMT mRNA, protein, and enzyme activity. Haplotype analysis reveals that different Val-containing haplotypes differ in their effects on soluble COMT (S-COMT) and membrane-bound COMT (MB-COMT) protein levels and enzyme activity. The 3'UTR SNP rs165599 G variant is associated with low COMT expression. A rare COMT mutation (rs74745580 'T') is associated with absent S-COMT expression and near-absent enzyme activity.\",\n      \"method\": \"COMT mRNA quantification, protein expression (Western blot), and enzyme activity assays in lymphoblast samples from 22q11.2DS patients and controls; haplotype analysis\",\n      \"journal\": \"Biological psychiatry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — concurrent mRNA, protein, and enzyme activity measurements in genetically defined patient samples with multiple haplotype contrasts\",\n      \"pmids\": [\"23992923\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Genetic reduction of either COMT or DTNBP1 (dysbindin) alone produces working memory advantages in mice, but combined reduction of both produces working memory deficits — a non-linear epistatic interaction. This same non-linear interaction is observed in human fMRI: COMT Met158 homozygotes (reduced COMT activity) show more efficient prefrontal engagement, but this advantage is reversed on the background of a DTNBP1 haplotype associated with decreased expression.\",\n      \"method\": \"COMT KO × DTNBP1 KO double-mutant mouse working memory behavioral testing; fMRI during working memory in 176 healthy volunteers stratified by COMT and DTNBP1 genotypes\",\n      \"journal\": \"Molecular psychiatry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis demonstrated in both animal model and human neuroimaging with convergent non-linear result\",\n      \"pmids\": [\"24145376\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"In the olfactory bulb (OB), COMT is the predominant mechanism for dopamine clearance rather than the dopamine transporter (DAT). The OB contains ~50% more COMT per unit tissue than the dopamine-rich striatum and far less DAT. Optical activation of short axon cells (SACs) expressing ChR2 in TH-containing neurons evokes dopamine release measured by fast-scan cyclic voltammetry; the COMT inhibitor tolcapone increases the DA signal ~2-fold, whereas the DAT inhibitor GBR12909 has no effect.\",\n      \"method\": \"Fast-scan cyclic voltammetry; optogenetic stimulation (ChR2 in TH-Cre mice); pharmacological COMT inhibition with tolcapone; Western blot quantification of COMT and DAT protein across brain regions\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct functional measurement of dopamine clearance with pharmacological inhibition and optogenetic release, orthogonal to protein quantification\",\n      \"pmids\": [\"27445153\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Transgenic mice overexpressing human COMT have lower basal striatal dopamine levels and, after 6-OHDA lesion and chronic L-DOPA treatment, exhibit exacerbated L-DOPA-induced dyskinesia with potentiated induction of FosB and phospho-acetylated histone 3 (molecular markers of dyskinesia) in the lesioned striatum. L-DOPA produces a greater increase in the dopamine metabolite 3-methoxytyramine in dyskinetic COMT-overexpressing mice, confirming enhanced COMT-mediated dopamine catabolism.\",\n      \"method\": \"Human COMT transgenic mouse model; 6-OHDA lesion; chronic L-DOPA treatment; dyskinesia scoring; striatal dopamine/metabolite HPLC; FosB and histone immunohistochemistry\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — gain-of-function transgenic model with defined neurochemical and molecular phenotype, multiple orthogonal readouts\",\n      \"pmids\": [\"28315782\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"In human prefrontal cortex (postmortem), COMT SNPs rs4680 (Val158Met) and rs4818 are associated with varying levels of soluble COMT (S-COMT) protein but not membrane-bound COMT (MB-COMT), indicating that genotype influences S-COMT abundance independently of MB-COMT. SNPs rs737865 and rs165599 showed no association with either isoform.\",\n      \"method\": \"Western blotting for S-COMT and MB-COMT protein in postmortem prefrontal cortex from 199 subjects with defined COMT genotypes at four SNPs; statistical association analysis stratified by diagnosis\",\n      \"journal\": \"Journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct protein quantification of two isoforms linked to specific SNPs in human tissue; single study\",\n      \"pmids\": [\"30218069\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"In iPSC-derived dopaminergic neurons from Parkinson's disease patients with PARK2 mutations, COMT expression is dramatically increased relative to healthy controls, associated with lower DNA methylation at the COMT locus. Isogenic PARK2 knockout lines (by CRISPR-Cas9) show the same COMT upregulation. Cell-type-specific overexpression of COMT in dopaminergic neurons of DAT-Cre mice produces cataleptic behavior and impaired motor coordination.\",\n      \"method\": \"iPSC differentiation to dopaminergic neurons; CRISPR-Cas9 isogenic PARK2 KO; RNA-seq and bisulfite sequencing for methylation; viral vector cell-type-specific COMT overexpression in DAT-Cre mice with behavioral phenotyping\",\n      \"journal\": \"Brain\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — isogenic CRISPR model plus in vivo cell-type-specific OE with defined motor phenotype; multiple orthogonal approaches\",\n      \"pmids\": [\"31135049\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"COMT-deficient pregnant mice develop a preeclampsia-like phenotype that is reversed by exogenous 2-methoxyestradiol (2-ME), an estrogen metabolite generated by COMT. 2-ME inhibits Hypoxia Inducible Factor 1α (HIF-1α), a transcription factor mediating hypoxic responses, linking COMT enzymatic activity to placental angiogenesis via the 2-ME/HIF-1α pathway.\",\n      \"method\": \"COMT KO pregnant mouse phenotyping; 2-ME supplementation rescue experiment; human genetic study of COMT and MTHFR haplotypes in preeclampsia cohort\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with pharmacological rescue identifies mechanistic pathway; human genetic epistasis data supporting mechanism\",\n      \"pmids\": [\"21304959\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"COMT encodes a magnesium-dependent O-methyltransferase (expressed as soluble S-COMT and membrane-bound MB-COMT isoforms) that inactivates catecholamines (dopamine, norepinephrine, epinephrine), catechol estrogens, and catechol drugs via S-adenosylmethionine-dependent O-methylation; a Val158Met coding polymorphism causes a ~3-4-fold difference in enzyme activity (Val=high, Met=low/thermolabile) that is further modulated by synonymous haplotype variants altering mRNA stem-loop structure and protein translation efficiency, thereby governing prefrontal dopamine levels (with MB-COMT predominating in human brain), mu-opioid system responses to pain, and downstream pathways including homocysteine production (via SAH) and 2-methoxyestradiol/HIF-1α-mediated placental angiogenesis; in the olfactory bulb, COMT rather than the dopamine transporter is the primary mechanism of synaptic dopamine clearance, and cell-type-specific overexpression or loss in dopaminergic neurons produces motor and cognitive phenotypes in rodent models.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"COMT is a magnesium- and S-adenosylmethionine-dependent O-methyltransferase that catalyzes the methylation of catechol substrates—including dopamine, norepinephrine, and catechol estrogens—and exists as membrane-bound (MB-COMT) and soluble (S-COMT) isoforms generated from alternative transcripts, with MB-COMT predominating catecholamine inactivation in human brain [PMID:11735324, PMID:27445153]. The common Val158Met polymorphism (rs4680) reduces S-COMT thermostability and catalytic activity, lowering methoxy-product formation from catechol estrogens and catecholamines, while additional coding (Ala72Ser) and regulatory (rs165599, rs737865) variants further modulate enzyme levels; in the olfactory bulb, COMT rather than the dopamine transporter is the primary dopamine clearance mechanism [PMID:11559542, PMID:15645182, PMID:30218069, PMID:27445153]. Beyond catecholamine metabolism, COMT-generated 2-methoxyestradiol suppresses HIF-1α signaling in placenta—Comt-knockout mice develop preeclampsia-like features reversible by exogenous 2-methoxyestradiol—and COMT is transcriptionally activated by ZNF804a, downregulated by estrogens in prefrontal cortex, and upregulated via promoter hypomethylation upon PARK2 loss in dopaminergic neurons, where COMT overexpression alone is sufficient to impair motor function [PMID:21304959, PMID:22384243, PMID:22100850, PMID:31135049]. Hemizygosity of COMT in 22q11.2 deletion syndrome halves enzyme activity and is linked to psychosis and cognitive impairment [PMID:23992923].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"The longstanding Val158Met polymorphism was biochemically resolved: purified recombinant Met108 COMT is thermolabile with 2–3-fold lower catalytic activity toward catechol estrogen substrates, establishing a direct structure-activity basis for the common functional polymorphism.\",\n      \"evidence\": \"In vitro enzymatic assay with purified recombinant Val108 and Met108 COMT; GC/MS product quantitation; cell-line validation (MCF-7, ZR-75)\",\n      \"pmids\": [\"11559542\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Thermostability difference shown in vitro but not confirmed with endogenous brain-derived protein\", \"In vivo catechol estrogen flux not measured\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Kinetic modeling clarified the species-specific isoform contribution, predicting that MB-COMT predominates dopamine/norepinephrine methylation in human brain (~70% of total COMT) while S-COMT predominates in rat brain, resolving why rodent and human pharmacological data diverged.\",\n      \"evidence\": \"Enzyme kinetic modeling using published Km/Vmax values for recombinant MB-COMT and S-COMT\",\n      \"pmids\": [\"11735324\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Prediction not validated by direct isoform-selective inhibition in human brain tissue\", \"Does not account for regional heterogeneity within human brain\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"COMT mRNA showed altered laminar distribution in schizophrenia prefrontal cortex but no correlation with Val158Met genotype at the mRNA level, indicating that the polymorphism's functional impact occurs post-transcriptionally (protein stability) rather than through mRNA feedback.\",\n      \"evidence\": \"In situ hybridization histochemistry on post-mortem DLPFC with Val158Met genotyping\",\n      \"pmids\": [\"12799619\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Protein-level quantification not performed in same samples\", \"Laminar expression change could reflect cell-type composition differences in disease\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"A second coding variant, Ala72Ser (rs6267), was shown to reduce COMT enzyme activity independently of Val158Met, expanding the allelic architecture influencing COMT function.\",\n      \"evidence\": \"Case-control genotyping (320 patients, 379 controls) with enzyme activity measurement correlated to Ala72Ser genotype\",\n      \"pmids\": [\"15645182\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Activity reduction not confirmed with purified recombinant Ser72 protein\", \"Single population (Korean); replication needed\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Regulatory SNPs (rs737865, rs165599) and Val158Met were each shown to modulate COMT mRNA levels in human cerebellum, with a pronounced sex dimorphism (higher female expression), revealing that COMT transcription is genetically and hormonally regulated.\",\n      \"evidence\": \"Quantitative RT-PCR on 60 post-mortem cerebellum samples; CpG methylation analysis; genotyping\",\n      \"pmids\": [\"16483362\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which rs737865 and rs165599 affect transcription not identified\", \"Cerebellum findings may not generalize to prefrontal cortex\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Multiple novel COMT mRNA variants with insertions and deletions were identified in human frontal cortex, revealing greater transcript complexity than the two canonical (MB/S) isoforms and raising the possibility of additional functional protein products.\",\n      \"evidence\": \"RT-PCR with intron-spanning primers; sequencing of amplicons from human brain\",\n      \"pmids\": [\"17477346\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No evidence that novel transcripts produce stable proteins\", \"Functional significance of variant transcripts untested\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"COMT Val158 carriers showed elevated plasma homocysteine selectively in MTHFR 677TT homozygotes, establishing an epistatic metabolic interaction whereby high COMT activity increases SAH/homocysteine flux when folate-cycle capacity is limited.\",\n      \"evidence\": \"Genotyping of 780 elderly subjects for COMT Val158Met and MTHFR C677T with plasma total homocysteine measurement\",\n      \"pmids\": [\"18189241\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"SAH levels not directly measured\", \"Direction of causality not experimentally confirmed\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Three concurrent studies established COMT's broader physiological roles: (1) COMT-generated 2-methoxyestradiol suppresses HIF-1α and its loss causes preeclampsia in mice, rescuable by 2-ME; (2) estrogens downregulate COMT protein in prefrontal cortex in vivo; and (3) COMT knockout increases stress-hormone responses and anxiety while altering benzodiazepine sensitivity.\",\n      \"evidence\": \"Comt KO mouse with 2-ME rescue (preeclampsia model); in vivo estradiol/tamoxifen treatment in rats with COMT Western blot/activity assay; COMT KO mice with corticosterone/cytokine measurement and pharmacological challenge\",\n      \"pmids\": [\"21304959\", \"22100850\", \"22192380\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"HIF-1α suppression mechanism not fully delineated at the molecular level\", \"Tissue-specific estrogen regulation of COMT not mapped genome-wide\", \"Anxiety phenotype sex-specific (females only); male phenotype unclear\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"ZNF804a was identified as a direct transcriptional activator of COMT by binding the COMT promoter region, providing the first defined upstream transcription factor for COMT in neural cells.\",\n      \"evidence\": \"ChIP with endogenous and epitope-tagged ZNF804a; overexpression in rat neural progenitor cells with quantitative RT-PCR\",\n      \"pmids\": [\"22384243\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"ZNF804a binding site not mapped to nucleotide resolution\", \"Effect on MB-COMT vs S-COMT promoter usage not distinguished\", \"No loss-of-function validation\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Two studies converged on COMT dosage effects in the brain: COMT hemizygosity in 22q11.2 deletion syndrome halves enzyme activity and specific haplotypes (rs165599 G, rs74745580 T) further reduce S-COMT expression/activity linked to psychosis; meanwhile, epistatic interaction with DTNBP1 demonstrated that COMT reduction improves working memory only in isolation, not when combined with dysbindin reduction.\",\n      \"evidence\": \"Lymphoblast COMT mRNA/protein/activity in 22q11.2DS subjects with haplotype analysis; double-mutant COMT×DTNBP1 mice with working memory testing replicated in human fMRI (N=176)\",\n      \"pmids\": [\"23992923\", \"24145376\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"22q11.2DS study used lymphoblasts, not neurons\", \"Mechanism of COMT×DTNBP1 epistasis at the circuit level not resolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"In the olfactory bulb, COMT was established as the predominant dopamine clearance mechanism over DAT re-uptake, with pharmacological COMT inhibition doubling evoked dopamine signals while DAT blockade had no effect—demonstrating a brain region where COMT is the rate-limiting step in dopamine inactivation.\",\n      \"evidence\": \"Quantitative COMT/DAT protein comparison; optogenetic DA release with fast-scan cyclic voltammetry; tolcapone vs GBR12909 in mouse olfactory bulb slices\",\n      \"pmids\": [\"27445153\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether COMT dominance extends to other low-DAT brain regions not tested\", \"Contribution of MB-COMT vs S-COMT in OB not resolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Human COMT overexpression in transgenic mice lowered striatal dopamine, increased 3-methoxytyramine, and exacerbated l-DOPA-induced dyskinesia with potentiated FosB and histone H3 phospho-acetylation, demonstrating that excessive COMT activity shifts dopamine metabolism toward intermittent signaling that worsens dyskinesia.\",\n      \"evidence\": \"Human COMT transgenic mice with 6-OHDA lesion; chronic l-DOPA; HPLC neurochemistry; dyskinesia scoring; FosB and H3 immunohistochemistry\",\n      \"pmids\": [\"28315782\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking elevated 3-MT to FosB/H3 modification not established\", \"Relevance to human l-DOPA therapy doses not confirmed\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Direct protein quantification in 199 human prefrontal cortex samples showed that rs4680 and rs4818 regulate S-COMT but not MB-COMT protein levels, resolving a long-debated question about which isoform carries the polymorphism's effect in the brain.\",\n      \"evidence\": \"Western blot quantification of S-COMT and MB-COMT in post-mortem prefrontal cortex; genotyping for four COMT SNPs\",\n      \"pmids\": [\"30218069\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which rs4818 affects S-COMT protein independently of Val158Met not identified\", \"MB-COMT protein regulation determinants remain unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"PARK2 (parkin) loss was shown to upregulate COMT via promoter DNA hypomethylation in iPSC-derived dopaminergic neurons, and cell-type-specific COMT overexpression in dopaminergic neurons was sufficient to produce motor impairment in mice, establishing a PARK2→COMT epigenetic axis in Parkinson's disease pathogenesis.\",\n      \"evidence\": \"iPSC-derived dopaminergic neurons from PARK2 patients and CRISPR isogenic controls; bisulfite sequencing; viral COMT overexpression in DAT-Cre mice with behavioral phenotyping\",\n      \"pmids\": [\"31135049\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether COMT upregulation is a primary pathogenic event or secondary to parkin loss-of-function proteostasis defects is unclear\", \"Downstream dopamine metabolite profile in iPSC neurons not reported\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: (1) the structural basis of MB-COMT membrane anchoring and its differential regulation from S-COMT; (2) the functional significance of the seven+ novel COMT transcript variants in brain; (3) the complete transcription factor network and epigenetic landscape controlling COMT expression across brain regions; and (4) whether COMT-targeted therapies can differentially modulate prefrontal vs striatal dopamine.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution structure of full-length MB-COMT with membrane domain\", \"Novel transcript protein products not confirmed\", \"Region-selective pharmacology not demonstrated\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 1, 7, 8, 12]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 1, 11, 13]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1, 13]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 1, 6, 7, 8, 12]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [7, 10, 12, 15]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"ZNF804A\",\n      \"DTNBP1\",\n      \"MTHFR\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"COMT is a magnesium- and S-adenosylmethionine-dependent O-methyltransferase that inactivates catecholamines (dopamine, norepinephrine) and catechol estrogens via O-methylation, expressed as soluble (S-COMT) and membrane-bound (MB-COMT) isoforms with MB-COMT predominating in human brain catecholamine metabolism at physiological substrate concentrations [PMID:11735324, PMID:11559542]. The common Val158Met polymorphism produces a 3–4-fold difference in catalytic activity and thermostability, and common synonymous haplotype variants further modulate enzyme output by altering mRNA stem-loop structure and translational efficiency, thereby governing prefrontal dopamine tone, pain sensitivity via the mu-opioid system, and homocysteine production through S-adenosylhomocysteine generation [PMID:8807664, PMID:17185601, PMID:12595695, PMID:18189241]. In the olfactory bulb, COMT rather than the dopamine transporter serves as the primary synaptic dopamine clearance mechanism, and cell-type-specific COMT overexpression in dopaminergic neurons produces catalepsy and motor impairment, while COMT-deficient mice exhibit altered stress-hormone responses, anxiety, and a preeclampsia-like phenotype rescued by the COMT product 2-methoxyestradiol [PMID:27445153, PMID:31135049, PMID:22192380, PMID:21304959]. COMT hemizygosity in 22q11.2 deletion syndrome halves mRNA, protein, and enzyme activity, and epistatic interactions with DTNBP1 genotype non-linearly modulate prefrontal working memory efficiency [PMID:23992923, PMID:24145376].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Establishing how a single coding variant controls COMT catalytic output: the Val158Met polymorphism was shown to cause a 3–4-fold difference in enzyme activity and thermostability, providing the first mechanistic basis for inter-individual variation in catecholamine metabolism.\",\n      \"evidence\": \"PCR-RFLP genotyping with enzyme activity assays in human erythrocytes and lymphocytes\",\n      \"pmids\": [\"8807664\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Crystal-structure basis for thermolability not defined in this study\", \"Effect on MB-COMT isoform not directly measured\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Defining substrate scope and isoform partitioning: recombinant enzyme assays demonstrated that Val158Met modulates catechol estrogen methylation with regioselectivity, while kinetic modeling showed that MB-COMT predominates in human brain dopamine O-methylation at physiological concentrations.\",\n      \"evidence\": \"Purified recombinant S-COMT and MB-COMT kinetic assays (GC/MS quantitation); kinetic modeling from published Km/Vmax values; validation in breast cancer cell lines\",\n      \"pmids\": [\"11559542\", \"11735324\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinetic model not validated by direct isoform-selective measurement in intact brain tissue\", \"Relative contribution of each isoform to catechol estrogen metabolism in vivo unknown\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Linking COMT genotype to prefrontal cognition: Val158Met was shown to predict executive function performance and prefrontal cortical efficiency in an allele-dosage manner, establishing that dopamine catabolism by COMT is rate-limiting for prefrontal cortical function.\",\n      \"evidence\": \"Neuropsychological testing (WCST) and fMRI during working memory in patients, siblings, and controls stratified by genotype; transmission disequilibrium test in schizophrenia trios\",\n      \"pmids\": [\"11381111\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Causal directionality (dopamine level vs. downstream signaling) not resolved\", \"Contribution of other prefrontal catecholamine-metabolizing pathways not excluded\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Extending COMT's functional reach beyond dopamine cognition: PET imaging revealed that Val158Met genotype modulates endogenous mu-opioid system responses to sustained pain, connecting catecholamine metabolism to opioid neurotransmission and pain processing.\",\n      \"evidence\": \"PET with [11C]carfentanil during experimental sustained pain, stratified by COMT genotype\",\n      \"pmids\": [\"12595695\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular pathway linking catechol metabolism to mu-opioid receptor activation not identified\", \"Whether the effect is dopamine- or norepinephrine-mediated is unresolved\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Revealing that synonymous haplotype variants, not Val158Met alone, are the dominant determinant of COMT enzyme output: synonymous SNPs alter mRNA local stem-loop structure, reducing translational efficiency and protein abundance, providing a post-transcriptional regulatory mechanism.\",\n      \"evidence\": \"Luciferase reporter assays with haplotype constructs; quantitative Western blotting; RNA structure prediction; site-directed mutagenesis rescue\",\n      \"pmids\": [\"17185601\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo validation of stem-loop-mediated translational control in brain tissue not performed\", \"Whether ribosome profiling data support the model is unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Connecting COMT catalysis to one-carbon metabolism: high-activity COMT Val158 carriers showed elevated plasma homocysteine (via SAH production), with an epistatic interaction with MTHFR C677T, establishing that COMT activity feeds into methionine cycle intermediates.\",\n      \"evidence\": \"Plasma homocysteine measurement in 780 elderly subjects stratified by COMT and MTHFR genotypes\",\n      \"pmids\": [\"18189241\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct measurement of SAH flux attributable to COMT not performed\", \"Replication in younger cohorts or different populations not reported\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identifying a non-catecholamine pathway for COMT in reproduction: COMT-deficient pregnant mice developed preeclampsia-like features reversed by the COMT product 2-methoxyestradiol, linking COMT to placental angiogenesis via 2-ME/HIF-1α inhibition.\",\n      \"evidence\": \"COMT KO pregnant mouse phenotyping with 2-ME rescue; human COMT/MTHFR haplotype association in preeclampsia cohort\",\n      \"pmids\": [\"21304959\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Human causal evidence limited to genetic association\", \"Quantitative contribution of COMT vs. other methyltransferases to 2-ME production in human placenta not defined\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Quantifying the functional consequence of COMT hemizygosity: in 22q11.2 deletion syndrome, COMT mRNA, protein, and enzyme activity are halved, and haplotype-specific effects on S-COMT vs. MB-COMT were resolved, including a rare variant ablating S-COMT expression.\",\n      \"evidence\": \"Concurrent mRNA, Western blot, and enzyme activity assays in 22q11.2DS patient lymphoblasts with full haplotype characterization\",\n      \"pmids\": [\"23992923\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Consequences for brain dopamine levels in 22q11.2DS patients not directly measured\", \"Functional impact of rare S-COMT-null variant not tested in neuronal cells\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Demonstrating non-linear epistasis in dopamine signaling: combined reduction of COMT and DTNBP1 reverses the working memory advantage seen with either reduction alone, in both mouse models and human fMRI, establishing that prefrontal dopamine function follows an inverted-U relationship dependent on multiple genetic inputs.\",\n      \"evidence\": \"COMT KO × DTNBP1 KO double-mutant mice behavioral testing; fMRI in 176 subjects stratified by both genotypes\",\n      \"pmids\": [\"24145376\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism of COMT–DTNBP1 interaction at the synaptic level not defined\", \"Whether the epistasis extends to pain or other COMT-dependent phenotypes unknown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Establishing COMT as the dominant dopamine clearance mechanism in the olfactory bulb: optogenetic dopamine release combined with pharmacological inhibition showed that tolcapone (COMT inhibitor) but not a DAT inhibitor prolonged dopamine signals, challenging the assumption that DAT is universally the primary clearance route.\",\n      \"evidence\": \"Fast-scan cyclic voltammetry with optogenetic stimulation in TH-Cre mice; tolcapone vs. GBR12909; COMT/DAT protein quantification across brain regions\",\n      \"pmids\": [\"27445153\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other brain regions with low DAT similarly depend on COMT clearance is unexplored\", \"Contribution of extracellular vs. intracellular COMT not dissected\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Linking COMT dysregulation to Parkinson's disease pathology: PARK2-mutant iPSC-derived dopaminergic neurons show COMT upregulation via DNA hypomethylation, and cell-type-specific COMT overexpression in dopaminergic neurons produces motor impairment, providing a gain-of-function disease-relevant mechanism.\",\n      \"evidence\": \"iPSC-derived dopaminergic neurons and isogenic CRISPR PARK2 KO lines (RNA-seq, bisulfite sequencing); AAV-mediated COMT overexpression in DAT-Cre mice with motor behavioral testing\",\n      \"pmids\": [\"31135049\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether COMT upregulation is causal to neurodegeneration or a compensatory response is unresolved\", \"Human in vivo confirmation of elevated COMT in PARK2 patient brains not shown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural basis for how MB-COMT membrane tethering alters substrate selectivity and regioselectivity remains undefined, and whether COMT inhibition can be leveraged therapeutically for prefrontal cognitive deficits or preeclampsia in humans lacks clinical evidence.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution structure of full-length MB-COMT in a membrane environment\", \"Clinical trial data for COMT modulation in cognition or preeclampsia absent from the timeline\", \"Cell-type-resolved COMT activity mapping across the full human brain not performed\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 1, 5, 7, 13]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [2, 13, 17]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [2, 13, 17]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 1, 5, 9, 15, 16]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [3, 4, 14, 15]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [4, 19]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"ZNF804A\",\n      \"DTNBP1\",\n      \"MTHFR\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}